Jove
Visualize
Contact Us

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fibrocystic Breast Changes.

Radiologic technology·2022
Same author

Ductography: When, How, and Why.

Radiologic technology·2021
Same author

Findings of the 2020 CT Workplace Survey.

Radiologic technology·2020
Same author

Challenges of the Underserved and Underscreened in Mammography.

Radiologic technology·2020
Same author

Improving Mammography Quality Through EQUIP.

Radiologic technology·2019
Same author

Adverse Effects and Imaging Appearances of Breast Implants.

Radiologic technology·2018
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 21, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.0K

Multiple Sclerosis: An Update.

Kathryn Faguy

    Radiologic Technology
    |May 6, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Multiple sclerosis (MS) is a common neurologic condition affecting young adults. Advances in treatments and diagnostics offer hope, but rising drug costs and misdiagnosis remain challenges.

    More Related Videos

    The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
    11:35

    The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

    Published on: June 30, 2014

    58.9K
    Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
    09:41

    Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

    Published on: July 19, 2019

    12.2K

    Related Experiment Videos

    Last Updated: Mar 21, 2026

    Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
    08:51

    Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

    Published on: February 19, 2021

    10.0K
    The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
    11:35

    The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

    Published on: June 30, 2014

    58.9K
    Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
    09:41

    Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

    Published on: July 19, 2019

    12.2K

    Area of Science:

    • Neurology
    • Immunology

    Background:

    • Multiple sclerosis (MS) is a leading cause of neurologic disability in young adults.
    • MS significantly impacts patient quality of life and incurs substantial societal costs.

    Purpose of the Study:

    • To provide a comprehensive review and update on multiple sclerosis.
    • To focus on risk factors, causes, symptoms, diagnostic criteria, and emerging treatments for MS.

    Main Methods:

    • Literature review of current research and clinical guidelines.
    • Analysis of diagnostic tools and therapeutic advancements.
    • Examination of economic and patient-specific factors related to MS.

    Main Results:

    • New treatments are available to slow MS progression.
    • Updated diagnostic criteria facilitate earlier and more effective treatment initiation.
    • Significant challenges include the high cost of MS drugs and instances of misdiagnosis.

    Conclusions:

    • Ongoing research and treatment advancements are improving MS management.
    • Addressing drug costs and diagnostic accuracy is crucial for optimal patient outcomes.
    • Special patient populations require tailored approaches to MS care.